The Biosimilar Therapeutic Peptides market size is expected to reach $6.11 billion in 2030 at a CAGR of 11.9%, driven by rising prevalence of chronic diseases.
Read More
The Biosimilar Monoclonal Antibodies market size is expected to reach $14.58 billion in 2030 at a CAGR of 6.6%, driven by growing autoimmune disease prevalence.
Read More
The Biosimilar Lymphocyte Modulator market size is expected to reach $3.53 billion in 2030 at a CAGR of 11.1%, driven by rising incidence of autoimmune disorders.
Read More
The Biosimilar Interleukins market size is expected to reach $41.22 billion in 2030 at a CAGR of 40.6%, driven by increasing prevalence of autoimmune diseases.
Read More
The Biosimilar Hormones market size is expected to reach $18.12 billion in 2030 at a CAGR of 23.9%, driven by rising healthcare expenditure and diabetes prevalence.
Read More
The Biosimilar Growth Hormones market size is expected to reach $1.46 billion in 2030 at a CAGR of 10.5%, driven by rising cases of growth hormone deficiency in children.
Read More
Biosimilar Contract Manufacturing Market Growth Is Accelerating As Industry Transformation Continues
The Biosimilar Contract Manufacturing market size is expected to reach $20.35 billion in 2030 at a CAGR of 15.4%, driven by growing prevalence of diabetes globally.
Read More
The Bioprocess Analyzers market size is expected to reach $3.35 billion in 2030 at a CAGR of 8.6%, driven by rising demand for biopharmaceutical production.
Read More
The Biopharmaceutical Lab Equipment market size is expected to reach $25.72 billion in 2030 at a CAGR of 7.6%, driven by increasing emphasis on personalized medicine.
Read More
The Biopharmaceutical Fermentation Systems market size is expected to reach $41.42 billion in 2030 at a CAGR of 9.4%, driven by expansion of the global biologics pipeline.
Read More